GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » Net Margin %

Suven Pharmaceuticals (BOM:543064) Net Margin % : 31.81% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Suven Pharmaceuticals's Net Income for the three months ended in Sep. 2024 was ₹820 Mil. Suven Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was ₹2,577 Mil. Therefore, Suven Pharmaceuticals's net margin for the quarter that ended in Sep. 2024 was 31.81%.

The historical rank and industry rank for Suven Pharmaceuticals's Net Margin % or its related term are showing as below:

BOM:543064' s Net Margin % Range Over the Past 10 Years
Min: 25.68   Med: 32.81   Max: 38.79
Current: 25.68


BOM:543064's Net Margin % is ranked better than
93.07% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs BOM:543064: 25.68

Suven Pharmaceuticals Net Margin % Historical Data

The historical data trend for Suven Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals Net Margin % Chart

Suven Pharmaceuticals Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial 38.79 36.40 34.72 30.90 28.99

Suven Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.43 21.27 22.48 26.34 31.81

Competitive Comparison of Suven Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Suven Pharmaceuticals's Net Margin % falls into.



Suven Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Suven Pharmaceuticals's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=3002.805/10358.465
=28.99 %

Suven Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=819.8/2577.2
=31.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suven Pharmaceuticals  (BOM:543064) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Suven Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Suven Pharmaceuticals Business Description

Traded in Other Exchanges
Address
No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081
Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Suven Pharmaceuticals Headlines

No Headlines